Alec Titan
Peripheral muscles are skeletal muscles that are controlled by the peripheral nervous system. The peripheral nervous system (PNS) is responsible for delivering command signals from the brain to the muscles, allowing for movement. Damage to the peripheral nervous system can cause peripheral muscle weakness, atrophy, and dysfunction. Peripheral muscle weakness is commonly observed in patients with chronic obstructive pulmonary disease (COPD) and cystic fibrosis (CF). Exercise training, particularly endurance and strength training, is an effective intervention for improving peripheral muscle strength and performance.
| Characteristics | Values |
|---|---|
| Peripheral muscle weakness | Prevalent in patients with cystic fibrosis, chronic obstructive pulmonary disease, and other chronic diseases |
| Peripheral muscle atrophy | Prevalent in patients with cystic fibrosis |
| Exercise intolerance | Caused by peripheral muscle dysfunction |
| Impaired functional status | Caused by low muscle mass in chronic obstructive pulmonary disease patients |
| Poor health-related quality of life | Caused by low muscle mass in chronic obstructive pulmonary disease patients |
| Impaired exercise capacity | Caused by peripheral muscle weakness |
| Muscle deconditioning | Caused by peripheral muscle weakness |
| Impaired gas exchange | Caused by peripheral muscle weakness |
| Altered effector function of peripheral cytotoxic cells | Observed in chronic obstructive pulmonary disease patients |
| Resistance training | Recommended to increase peripheral muscle strength in chronic obstructive pulmonary disease patients |
Explore related products
What You'll Learn
Peripheral muscle weakness and cystic fibrosis
Peripheral muscles refer to skeletal muscles, which are the muscles that are attached to the skeleton and allow the body to move. Peripheral muscle weakness is a common issue in patients with cystic fibrosis (CF). Peripheral muscle dysfunction is a significant consequence of CF, impacting the lives of those with the disease.
There are several clinical implications associated with peripheral muscle weakness in CF patients. One of the major implications is exercise intolerance, which is a reduced capacity for exercise. This can lead to a decrease in the quality of life for those with CF. The muscle weakness is associated with reduced aerobic and anaerobic performances, meaning that the peripheral muscles of CF patients fatigue more quickly and have a lower endurance than those of healthy individuals.
While physical inactivity is a contributing factor to peripheral muscle weakness in CF patients, it is not believed to be the sole cause. Research suggests that CF-related factors, such as inflammation and metabolic abnormalities, are also likely to be involved. The specific causes and mechanisms of peripheral muscle dysfunction in CF are still being investigated, with studies combining data from human and animal models to improve understanding.
Exercise training is the most effective intervention for addressing peripheral muscle dysfunction in CF patients. It improves muscle strength and endurance, and can increase the quality of life for those with CF. Other interventions that may be beneficial include neuromuscular electrical stimulation, nutritional or hormonal supplementation, and pharmacological interventions such as CFTR modulators.
Future research directions include combining measurements at the cellular level with indices of muscle function and monitoring physical activity levels to better understand the etiology of peripheral muscle dysfunction in CF.
Flexing Your Knees: Which Muscles Are Involved?
You may want to see also
Explore related products
Peripheral muscle wasting in chronic obstructive pulmonary disease
Peripheral muscle wasting, or muscle atrophy, is a common occurrence in patients with advanced chronic obstructive pulmonary disease (COPD). This condition is characterised by low-grade systemic inflammation, which is often accompanied by low blood levels of anabolic hormones. Cachexia, a condition characterised by weight loss, weakness, and fatigue, is a common symptom of COPD and other chronic diseases, including chronic heart failure, renal failure, cancer, and acquired immunodeficiency syndrome (AIDS).
In COPD, peripheral muscle weakness and loss of strength are prevalent, affecting the patient's quality of life and survival. Upper arm and leg muscles are more affected than hand muscles, and chronic inactivity and muscle deconditioning are believed to be contributing factors to the loss of muscle mass and strength. Furthermore, elevated CO2 levels have been found to delay skeletal muscle repair by increasing fatty acid oxidation.
The exact mechanisms leading to muscle wasting in COPD are not yet fully understood, but recent advances in clinical research have confirmed the negative impact of muscle wasting on patient survival. Studies have also shown that muscle mass can be successfully manipulated in wasting disorders, offering therapeutic opportunities to tackle muscle wasting and potentially improve patients' quality of life.
While effective treatments for muscle wasting in COPD have not yet been developed, exercise training has been found to be beneficial. Endurance exercises such as cycling and treadmill walking can improve exercise capacity and alter muscle metabolism. Strength training of peripheral muscles can also lead to increases in submaximal exercise performance and quality of life measures. Additionally, other strategies such as neuromuscular electrical stimulation and nutritional or hormonal supplementation may be considered for some patients.
Intercostal Muscles: Mnemonic Strategies for Easy Recall
You may want to see also
Explore related products
Peripheral muscle dysfunction and exercise intolerance
Peripheral muscle refers to skeletal muscles in the body's extremities, such as the arms and legs. Peripheral muscle dysfunction is a condition that affects individuals with specific diseases or disorders, such as cystic fibrosis (CF) and chronic obstructive pulmonary disease (COPD). This dysfunction is characterised by peripheral muscle atrophy and weakness, leading to reduced exercise performance and intolerance.
Exercise intolerance is a common symptom in individuals with peripheral muscle dysfunction, particularly those with CF and COPD. These individuals experience a reduced capacity to perform physical activities, accompanied by symptoms such as dyspnea (difficulty breathing) and fatigue. The peripheral muscle weakness associated with COPD is due to muscle atrophy and chronic inactivity, resulting in a loss of muscle mass and strength. Similarly, physical inactivity is believed to be a significant contributor to peripheral muscle abnormalities in patients with CF. However, as the disease severity increases, other factors such as inflammation and metabolic abnormalities play a more prominent role.
In patients with CF, peripheral muscle dysfunction has major clinical implications, impacting their quality of life. The lack of physical activity alone may not fully explain the peripheral muscle dysfunction in these patients. Instead, intrinsic CF-related factors, such as CFTR expression in skeletal muscle, are also implicated. Exercise training is the most effective intervention for peripheral muscle dysfunction in CF patients. Additionally, neuromuscular electrical stimulation, nutritional or hormonal supplementation, and pharmacological interventions may be considered based on individual needs.
For individuals with COPD, peripheral muscle weakness, deconditioning, and impaired gas exchange contribute significantly to their exercise intolerance. Quadriceps strength and muscle cross-sectional area are reduced in these patients, indicating muscle atrophy. Furthermore, peripheral muscle training modalities, such as endurance exercises like cycling and treadmill walking, have been shown to improve exercise capacity and muscle metabolism. Strength training of peripheral muscles has also led to increases in submaximal exercise performance.
In summary, peripheral muscle dysfunction and exercise intolerance are closely linked, particularly in individuals with CF and COPD. Exercise intolerance results from a combination of reduced muscle strength, endurance, and impaired gas exchange. While exercise training is the primary intervention, a multidisciplinary approach that addresses the specific needs of each patient is necessary to manage peripheral muscle dysfunction effectively.
Vocal Fold Tension: Muscles at Play
You may want to see also
Explore related products
Resistance training of peripheral muscles
Peripheral muscles are those that are away from the body's core, such as the upper arm and leg muscles. Peripheral muscle weakness is common in patients with chronic obstructive pulmonary disease (COPD). This is due to muscle atrophy and deconditioning caused by chronic inactivity.
In patients with COPD, peripheral muscle training can improve exercise performance and capacity. Endurance exercises such as cycling and treadmill walking can lead to alterations in muscle metabolism and improved exercise capacity. Strength training of peripheral muscles has been shown to increase submaximal exercise performance and quality of life measures, regardless of the degree of airflow obstruction.
High-intensity resistance training (HIRT) has been found to benefit older women with sarcopenia, a condition characterised by a decrease in muscle mass and strength that affects respiratory function. HIRT interventions can increase muscle strength, halt age-related respiratory function decline, and improve health-related quality of life in this population.
Overall, resistance training of peripheral muscles can be a safe and effective approach for improving muscle strength and function, as well as cardiovascular health, in various populations.
The Truth About Noses: Muscles or Not?
You may want to see also
Explore related products
Peripheral muscle abnormalities and therapeutic interventions
Peripheral muscles are skeletal muscles that are under voluntary control and are associated with limbs and movement. Peripheral muscle abnormalities are commonly observed in patients with cystic fibrosis (CF) and chronic obstructive pulmonary disease (COPD). These abnormalities can manifest as muscle atrophy, weakness, and reduced aerobic and anaerobic performances, leading to significant clinical implications such as exercise intolerance and a decreased quality of life.
Therapeutic interventions for peripheral muscle abnormalities aim to address these issues and improve patients' overall well-being. One of the most effective interventions is exercise training, which has been shown to improve muscle strength, endurance, and metabolism. For instance, endurance exercises like cycling and treadmill walking can enhance exercise capacity and muscle metabolism. Strength training of peripheral muscles can also lead to increases in submaximal exercise performance and quality of life measures.
In addition to exercise training, other strategies may be employed as part of a comprehensive treatment plan. Neuromuscular electrical stimulation, nutritional supplementation, and hormonal supplementation have been suggested as potential interventions for peripheral muscle dysfunction. Furthermore, pharmacological interventions, such as CFTR modulators, are being investigated as possible treatments.
The specific therapeutic interventions implemented depend on the underlying condition and the severity of the patient's symptoms. For instance, in patients with CF, the relative influence of factors such as inflammation and metabolic abnormalities increases with disease severity, necessitating specific and individualized interventions for severe cases. Additionally, future studies are combining measurements at the cellular level with indices of muscle function to better understand the etiology of peripheral muscle dysfunction in CF and guide more targeted treatments.
In summary, peripheral muscle abnormalities can significantly impact patients' lives, and therapeutic interventions play a crucial role in managing these abnormalities. While exercise training is a cornerstone of treatment, a multidisciplinary approach that considers the unique needs of each patient is essential for optimizing outcomes.
Exploring the Anatomy of Fascia and Fascicle Interactions
You may want to see also
Frequently asked questions
Peripheral muscles are skeletal muscles that are found outside of the body's vital organs.
Peripheral muscle weakness is often caused by inactivity and muscle deconditioning. It is commonly found in patients with chronic obstructive pulmonary disease (COPD) and cystic fibrosis (CF).
Exercise training, particularly resistance training, is recommended to improve peripheral muscle strength. Endurance exercises such as cycling and treadmill walking can also help improve exercise capacity.
